Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. (Q51910877)
Jump to navigation
Jump to search
scientific article published in July 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. |
scientific article published in July 2007 |
Statements
1 reference
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. (English)
1 reference
1 reference
Beatriz Grinsztejn
1 reference
José Valdez Madruga
1 reference
Pedro Cahn
1 reference
Richard Haubrich
1 reference
Jacob Lalezari
1 reference
Gilles Pialoux
1 reference
Timothy Wilkin
1 reference
Monika Peeters
1 reference
Johan Vingerhoets
1 reference
Goedele de Smedt
1 reference
Lorant Leopold
1 reference
Roberta Trefiglio
1 reference
Brian Woodfall
1 reference
DUET-1 study group
1 reference
1 July 2007
1 reference
1 reference
370
1 reference
9581
1 reference
29-38
1 reference
Identifiers
1 reference